Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response (Q36303452)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

ejection fraction

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

James D Lewsey

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Barry M Massie

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Peter E Carson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Robert S McKelvie

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

JoAnn Lindenfeld

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michel Komajda

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

6 August 2015

1 reference

Europe PubMed Central

13 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

925-935

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Clinical implications of chronic heart failure phenotypes defined by cluster analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Phenomapping for novel classification of heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Multiple imputation using chained equations: Issues and guidance for practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Epidemiology and clinical course of heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Use and misuse of the receiver operating characteristic curve in risk prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Prognostic value of a novel classification scheme for heart failure: the Minnesota Heart Failure Criteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

30 September 2017

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

22 September 2018

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4654630

22 September 2018

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

21 January 2018

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

21 January 2018

Systolic and Diastolic Heart Failure Are Overlapping Phenotypes Within the Heart Failure Spectrum

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

21 January 2018

Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

7 January 2021

based on heuristic

inferred from DOI database lookup

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.327

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.327

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250359%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36303452&oldid=1866498712"